|
|
||||||||
1 Department of Cell Biology and Neuroscience, Rutgers University, Piscataway, New Jersey 08854-8082; 2 Department of Pharmacology and Toxicology, West Virginia University, Morgantown, West Virginia 26506; and 3 Department of Obstetrics and Gynecology, Winthrop University Hospital, Mineola, New York 11501
Acetaminophen is a phenol with antioxidant properties, but little is known about its actions on the mammalian myocardium and coronary circulation. We studied isolated, perfused guinea pig hearts, and tested the hypothesis that acetaminophen-treated hearts would be protected during ischemia-reperfusion. Acetaminophen concentrations in the range of 0.3-0.6 mmol/l caused modest but significant (P < 0.05) coronary vasoconstriction and positive inotropy. The effects were more brisk during constant pressure perfusion than during constant flow. During 20 min of low-flow, global myocardial ischemia and 40 min of reperfusion, hearts treated with acetaminophen retained or recovered a greater percentage of left ventricular function than hearts treated with vehicle. Myofibrillar ultrastructure appeared to be preserved in the reperfused myocardium with acetaminophen. By using chemiluminescence and spin-trap methodologies, we investigated acetaminophen-mediated antioxidant mechanisms to help explain the cardioprotection. The burst of hydroxyl radicals seen between 0 and 10 min of reperfusion was significantly attenuated (P < 0.05) by acetaminophen but not by vehicle. The 3-morpholinosydnominine (SIN-1) generation of peroxynitrite and its oxidative interaction with luminol to produce blue light during ischemia-reperfusion was also blocked by acetaminophen. Our results show that acetaminophen provides significant functional and structural protection to the ischemic-reperfused myocardium, and the mechanism of cardioprotection seems to involve attenuation of the production of both hydroxyl radicals and peroxynitrite.
peroxynitrite; hydroxyl radicals; functional preservation; heart
This article has been cited by other articles:
![]() |
N. M. Hadzimichalis, S. S. Baliga, R. Golfetti, K. M. Jaques, B. L. Firestein, and G. F. Merrill Acetaminophen-mediated cardioprotection via inhibition of the mitochondrial permeability transition pore-induced apoptotic pathway Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3348 - H3355. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Merrill, J. H. Merrill, R. Golfetti, K. M. Jaques, N. S. Hadzimichalis, S. S. Baliga, and T. H. Rork Antiarrhythmic Properties of Acetaminophen in the Dog Experimental Biology and Medicine, October 1, 2007; 232(9): 1245 - 1252. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Walker Jr., C. P. Epling, C. Parris, S. Cansino, P. Ghosh, D. H. Desai, R. G. Morrison, G. L. Wright, P. Wehner, E. I. Mangiarua, et al. Acetaminophen Protects Against Iron-Induced Cardiac Damage in Gerbils Ann. Clin. Lab. Sci., January 1, 2007; 37(1): 22 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pacher, J. S. Beckman, and L. Liaudet Nitric Oxide and Peroxynitrite in Health and Disease Physiol Rev, January 1, 2007; 87(1): 315 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Leshnower, H. Sakamoto, A. Zeeshan, L. M. Parish, R. Hinmon, T. Plappert, B. M. Jackson, J. H. Gorman III, and R. C. Gorman Role of acetaminophen in acute myocardial infarction Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2424 - H2431. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Kevin, E. Novalija, and D. F. Stowe Reactive Oxygen Species as Mediators of Cardiac Injury and Protection: The Relevance to Anesthesia Practice Anesth. Analg., November 1, 2005; 101(5): 1275 - 1287. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Rork, K. Van Dyke, N. M. Spiler, and G. F. Merrill Acetaminophen in the Hypoxic and Reoxygenated Guinea Pig Myocardium Experimental Biology and Medicine, December 1, 2004; 229(11): 1154 - 1161. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Merrill, T. H. Rork, N. M. Spiler, and R. Golfetti Acetaminophen and myocardial infarction in dogs Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H1913 - H1920. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Dai and R. A. Kloner Effects of Acetaminophen on Myocardial Infarct Size in Rats Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2003; 8(4): 277 - 284. [Abstract] [PDF] |
||||
![]() |
R. Golfetti, T. Rork, and G. Merrill Chronically Administered Acetaminophen and the Ischemia/Reperfused Myocardium Experimental Biology and Medicine, June 1, 2003; 228(6): 674 - 682. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Marshall, P. Powers-Risius, B. W. Reutter, A. M. Schustz, C. Kuo, M. K. Huesman, and R. H. Huesman Flow heterogeneity following global no-flow ischemia in isolated rabbit heart Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H654 - H667. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Golfetti, K. VanDyke, T. Rork, N. Spiler, and G. Merrill Acetaminophen in the Post-ischemia Reperfused Myocardium Experimental Biology and Medicine, December 1, 2002; 227(11): 1031 - 1037. [Abstract] [Full Text] |
||||
![]() |
G. F. Merrill Acetaminophen and low-flow myocardial ischemia: efficacy and antioxidant mechanisms Am J Physiol Heart Circ Physiol, April 1, 2002; 282(4): H1341 - H1349. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |